We serve Chemical Name:(4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione CAS:1206102-10-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![(4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione](https://a.dearchem.com/CAS2/1206102-10-4.png)
Chemical Name:(4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione
CAS.NO:1206102-10-4
Synonyms:2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-6,8-dione, 9-bromo-3,4,12,12a-tetrahydro-4-methyl-7-(phenylmethoxy)-, (4R,12aS)-;(4R,12aS)-7-(benzyloxy)-9-bromo-4-methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione;(4R,12aS)-7-(Benzyloxy)-9-bromo-4-methyl-3,4,12,12a-tetrahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-6,8-dione
Molecular Formula:C19H19BrN2O4
Molecular Weight:419.269
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:599.7±50.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.667
PSA:60.77000
Exact Mass:418.052826
LogP:0.28
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-6,8-dione, 9-bromo-3,4,12,12a-tetrahydro-4-methyl-7-(phenylmethoxy)-, (4R,12aS)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4R,12aS)-7-(Benzyloxy)-9-bromo-4-methyl-3,4,12,12a-tetrahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-6,8-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-6,8-dione, 9-bromo-3,4,12,12a-tetrahydro-4-methyl-7-(phenylmethoxy)-, (4R,12aS)- Use and application,2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-6,8-dione, 9-bromo-3,4,12,12a-tetrahydro-4-methyl-7-(phenylmethoxy)-, (4R,12aS)- technical grade,usp/ep/jp grade.
Related News: The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione manufacturer The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione supplier With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs. (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione vendor The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon. (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione factory The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful.
